ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,490, issued on Sept. 2, was assigned to NantOmics LLC (Culver City, Calif.).
"AGGF1 immunogenic compositions" was invented by Stephen Charles Benz (Culver City, Calif.), Andrew Nguyen (Culver City, Calif.), Charles Joseph Vaske (Culver City, Calif.) and John Zachary Sanborn (Culver City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Certain universal neoepitopes and cancer specific neoepitopes and methods therefor are presented that may be used in immunotherapy and cancer diagnosis. Preferred therapeutic and diagnostic compositions include antibodies or fragments thereof that bind to neoepitopes on cancer cells."
The patent was filed on Oct...